![]()
MIRA INFORM REPORT
|
Report Date : |
25.02.2011 |
IDENTIFICATION DETAILS
|
Name : |
ZETA PHARMACEUTICALS LLC |
|
|
|
|
Formerly Known As : |
DWL CONSULTING LLC |
|
|
|
|
Registered Office : |
|
|
|
|
|
Country : |
|
|
|
|
|
Date of Incorporation : |
26.04.2006 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Pharmaceuticals Drugs and Pharmaceutical Products wholesalers |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 100,000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment
Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30, 2010
|
Country Name |
Previous Rating (01.04.2010) |
Current Rating (30.06.2010) |
|
|
a1 |
a1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
POLITICAL DATA |
ECONOMIC DATA |
|
|
Form of Government: Federal
|
Currency: USD |
|
Ordered as: |
Zeta Pharmaceuticals LLc |
|||
|
Address in the order: |
|
|||
|
Legal Name: |
ZETA PHARMACEUTICALS LLC |
|||
|
Legal Address |
|
|||
|
Operative Address |
|
|||
|
Telephone: |
+1 (201) 930-4934 |
ID : |
3353519 |
|
|
Fax: |
+1 (201) 930-4936 |
Legal Form: |
Limited Liability Company |
|
|
Email: |
Registered in: |
|
||
|
Website: |
Date Created: |
2001 |
||
|
Manager: |
Dieter W. Luelsdorf, President |
Date Incorporated: |
April 26th, 2006 |
|
|
Staff: |
10 |
Stock: |
NA |
|
|
|
|
Value: |
NA |
|
|
Activity: |
Pharmaceuticals Drugs and Pharmaceutical Products wholesalers. |
|||
|
Name of the Bank |
TD Bank |
|
HISTORY |
||
|
|
The company was founded in 2001. It was formerly known as DWL CONSULTING LLC, and changed its name to
ZETA PHARMACEUTICALS LLC in MAY 11, 2009. |
|
|
PRINCIPAL ACTIVITY |
||
|
|
This company wholesales Pharmaceuticals Drugs and Pharmaceutical
Products. The company imports bulk active and inactive ingredients for the It emphazises in OTC and prescription pharmaceutical markets. The company offers a broad and diversified range of APIs to human and
veterinary dosage manufacturers. |
|
|
Products/Services description: |
||
|
|
ACTIVE OTC INGREDIENTS: Acetaminophen (Various mesh sizes) Acetaminophen, DC grade Acetaminophen, 8 hr. CR Aspirin (Various mesh sizes) Aspirin DC-90 Bismuth Subsalicylate (Regular & Suspension Grade) Caffeine Anhydrous (Crystalline & Powder) Calcium Polycarbophil Dextromethorphan HBr Diphenhydramine HCl Docusate Sodium, 85% Hydrocortisone Base and HCl Hyoscyamine Sulfate Icthammol Methscopolamine Nitrate Methenamine Pamabrom Polyethylene Glycols Among Others Generics: Allopurinol Alprazolam Bicalutamide Carisoprodol Clindamycin HCl Clindamycin Phosphate Clonazepam Chlordiazepoxide HCl Diazepam Divalproex, Sodium Donepezil HCl Fluorouracil Galantamine HBr Glimepiride Guaifenesin Isosorbide Mononitrate Lisinopril Loratidine Lorazepam Losartan Potassium Lovastatin Metformin HCl Methylphenobarbital Metoprolol Succinate Modafinil Niacin Oxybutynin HCl Among others Generic Pipeline: Adapalene Alfuzosin HCl Allopurinol, Sodium Bisoprolol Fumerate Benztropine Mesylate Capecitabine Caspofungin Clavulanate, Potassium Cyclobenzaprine HCl Desonide Desvenlafaxine Epirubicin HCl Eplenerone Fluticasone Propionate Gemcitabine HCl Hydroxyzine HCl Ifosfamide Ipratropium Bromide Irinotecan HCl Isoflurane Isradipine Levalbuterol HCl Levalbuterol Tartrate Mesna Metaxalone Among others |
|
|
Sales are: |
||
|
|
Wholesale |
|
|
Brands: |
||
|
|
Harman Finochem Nantong Jinghua Pharmaceutical Company Stearinerie Dubois Company |
|
|
Suppliers: |
||
|
|
Harman Finochem Stearinerie Dubois Company (France) Nantong Jinghua Pharmaceutical Company |
|
|
Operations area: |
||
|
|
National, International |
|
|
The company imports from Asia, Europe and |
||
|
The company export to |
||
|
PAYMENTS |
||
|
|
regular |
|
|
LOCATION |
||
|
Headquarters |
||
|
|
The company is headquartered at |
|
|
Listed at the stock exchange: |
||
|
|
NO |
|
|
Shareholders Parent Company(ies): |
||
|
|
This company is privately held. Dieter W. Luelsdorf is one of the main
shareholder. |
|
|
Management: |
||
|
|
Dieter W. Luelsdorf, President Susan Navarro, Accountant Irene Chourrot, Customer Service |
|
|
As a private company‚ the subject does not publish any financial
statements. |
|
|
We have contacted Susan who refused to provide us any financial data
on grounds of confidentiality without knowing the name of the inquiring
party. |
|
|
However our financial sources could provide us with the following
data. Those figures are estimates provided by confidential banking and
financial institutions working with the company. |
|
Currency |
DATE |
|
USD |
2009 |
|
Turnover |
7,340,000 |
|
Net Income |
367,000 |
|
Net worth |
600,000 |
|
Liabilities |
931,000 |
|
The cash flow is |
|
|
Legal Fillings |
|
|
There is one UCC files listed with the
Secretary of State of New York. There are no legal filings listed with the
District Court. THE COMPANY IS NOT LISTED ON THE OFAC
LIST.* For information: * The Specially Designated Nationals (SDN)
List is a publication of OFAC which lists individuals and organizations with
whom ** The Uniform Commercial Code (UCC) is
one of a number of uniform acts that have been promulgated in conjunction
with efforts to harmonize the law of sales and other commercial transactions
in all 50 states within the The UCC deals primarily with transactions
involving personal property (movable property), not real property (immovable
property). It allows a creditor to notify other
creditors about a debtor's assets used as collateral for a secured
transaction by filing a public notice (financing statement) with a particular
filing office. The Uniform Commercial Code Bureau files
and maintains on financial obligations (including IRS liens) incurred by
individuals (in business as a sole proprietor), business entities and
corporations. |
|
Local credit bureau gave a Low credit
rate. The company is in Good Standing. This
means that all local and federal taxes were paid on due date. |
||
|
Final Opinion |
||
|
|
This is a small sized company, with 10
employees and 10 years of experience. There were no legal filings found against
the company or its legal representatives. We have contacted the company but they
refused to provide us with any financial information without knowing the name
of the inquiring party. The company gave a good profitability for
the year 2009. A credit line may be considered for USD
100,000 |
|
|
|
|
|||
|
Profitability |
CORRECT |
Public Records |
NO |
|
|
Indebtedness |
N.A. |
Payments |
REGULAR |
|
|
Cash |
N.A. |
|
|
|
|
Person Interviewed |
||
|
|
Susan Novarro |
|
|
Position |
||
|
|
Accountant |
|
|
Comments |
||
|
|
She refused to provide us with any information about the company
without knowing the exact name of the inquiring party, due to confidentiality
reasons. |
|
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.37 |
|
|
1 |
Rs.73.54 |
|
Euro |
1 |
Rs.62.39 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.